Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Comment by malibukion Oct 02, 2017 1:58pm
135 Views
Post# 26767290

RE:RE:RE:RE:RE:RE:new financials are out

RE:RE:RE:RE:RE:RE:new financials are out
Have not we experienced tech validation and total impact scenario with Valeant deal? I am aware that 90M is too much at this stage but using this figure in investor slides and getting only 5% of this is a big fail in every metrics. Especially if there are more than 1 parties in disscusions as claimed.

After all missed promises I am not that optimistic with for the rest of the pipeline to be materalized in a reasonable time. There was not a  single met goal on proposed time frame in the last 3 years, why to believe things would change in the future?

Pipeline is not valued zero, considering what we have delivered until now, more than 20M market cap is even inflated to be honest. And a small upfront would hardly move this up.

Wex I really like your optimism and I think world would have been a better place if we had more people like you, but which earnings are you talking about? Except upfronts (mostly would be used to pay loans and MOA studies etc) there is no cash flow in the horizon. 





Bullboard Posts